Voices of Progress Highlights Accomplishments During Financially Challenging Environment
New York, New York (PRWEB) September 10, 2009 -- The Crohn's & Colitis Foundation of America, the leading nonprofit aimed at finding a cure for the 1.4 million Americans living with Crohn's disease and ulcerative colitis, chronic and painful digestive diseases, today announced that its 2008 Annual Report, Voices of Progress is available at http://www.ccfa.org/about/annual_report.
The 2008 fiscal year was a watershed year for the Foundation as it reached new fundraising and research milestones. Over $15.5 million was invested in research this year, roughly two and a half times what the Foundation allocated only a couple of years ago. This allowed the Foundation to fund 53 research projects, an excellent accomplishment in what continues to be a financially challenging environment. The report shows how donated funds are being well spent in support of the organization's research and other key initiatives.
"This year's annual report serves well as a reminder of what a committed organization can accomplish," says Richard J. Geswell, President of the Crohn's & Colitis Foundation of America. "Not only has the Crohn's & Colitis Foundation doubled its research investment in only a few years, but expanded its advocacy and patient and professional programs on a local and national level, reaching new heights, delivering up-to-date, critical information and support to the Crohn's and colitis community."
In the world of basic and clinical research, Crohn's & Colitis Foundation investments became highly visible during this fiscal year. The report prominently features the progress by top scientists and physicians in the Foundation's Human Gut Microbiome Initiative and its Pediatric Network's Risk Stratification in Crohn's Initiative. The report also discusses the Pregnancy Registry of the Clinical Alliance, which has made impressive headway in gaining timely information about pregnancy and post-natal outcomes in women with Crohn's and colitis. The report explains that crucial work like this provides short-term improvements in patient care and a foundation for applying scientific discoveries to patient-based research.
In addition, the Foundation's many patient and professional education, patient support programs, advocacy, and key fundraising initiatives are reviewed in the report, revealing many milestones accomplished during the 2008 fiscal year.
About Crohn's Disease and Ulcerative Colitis
Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.
About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance and the American Institute of Philanthropy. For more information, contact the Foundation at 800-932-2423 or visit the CCFA web site.
Crohn's & Colitis Foundation
# # #
Read the full story at http://www.prweb.com/releases/2009/09/prweb2857824.htm.
Copyright©2009 Vocus, Inc.
All rights reserved